Yatharth Hospital & Trauma Care Services Limited announced on November 12, 2026, that it has received approval from the Competition Commission of India (CCI) for its proposed preferential issue. This issue aims to raise an aggregate cash consideration of approximately INR 31,500 million from Rasmalai Limited. The transaction is subject to other regulatory requirements, and the issuance will result in Rasmalai Limited holding a minority investment of 24.87% post-issue.
CCI Approves Preferential Issue
Yatharth Hospital & Trauma Care Services Limited has announced that the Competition Commission of India (CCI) has granted its approval for the company’s proposed preferential issue. This significant development was communicated via a letter dated November 10, 2026, from the CCI.
Details of the Preferential Issue
The preferential issue, intended to raise an aggregate cash consideration of approximately INR 31,500 million, is being made on a private placement basis to Rasmalai Limited. This entity is incorporated under the laws of Cyprus. The securities to be issued and allotted will represent a minority investment of 24.87% of the company’s post-issue share capital on a fully diluted basis. The company had previously informed the stock exchanges about this proposed issuance on September 22, 2026.
Regulatory Compliance
This communication is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. While the CCI approval has been secured, the transaction remains contingent upon the fulfillment of other applicable regulatory and statutory requirements. The company has also committed to making this disclosure available on its website.
Source: BSE
